Study: Elmajnoun 2023, Diabetes Therapy
Effects of Ramadan Fasting on Glycaemic Control Among Patients with Type 2 Diabetes: Systematic Review and Meta-analysis of Observational Studies
Citation
Elmajnoun HK, Faris ME, Abdelrahim DN, Haris PI et al (2023). Diabetes Therapy. PubMed id 36725794.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Fasting in Ramadan with diabetes or sickle cell Tier B thin
B 5,554 adults with type 2 diabetes in 12 observational studies from Middle Eastern and Asian countries (n=12 studies (5,554 people))
Systematic review and meta-analysis of before-and-after studies of Ramadan fasting.
HbA1c and fasting blood glucose were significantly lower after Ramadan than before it (heterogeneity high, about 93% and 81%); body weight did not change. The authors call the outcomes favourable and say effects of diet, activity and sleep need study. No study looked only at young adults.
As recorded in this card: Elmajnoun HK, Faris ME, Abdelrahim DN, Haris PI et al (2023), Diabetes Therapy, [review]
Note: No control group of non-fasters; people who choose to fast may be healthier. The studies were not in Black populations.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.